Deferoxamine stability in intravenous solution

Annals of the New York Academy of Sciences

Volumn 850, Issue , 1998, Pages 488-489

  Rose, C ^a,b   Gambie C ^b   Forzy, G ^a   Mahieu, M ^a   Penaux, P ^b   Bauters, F ^b  

^a Groupement Hospitalier de L'Institut Catholique Facultél Libre de Méldecine de Lille   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; DEFEROXAMINE;

BLOOD TRANSFUSION; CONFERENCE PAPER; DRUG STABILITY; DRUG STORAGE; INFUSION PUMP; INTRAVENOUS DRUG ADMINISTRATION; IRON OVERLOAD; TEMPERATURE;

EID: 0031824745     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10529.x     Document Type: Conference Paper

References (6)

1. BRTTTENHAM, G. M., P. M. GRIFFITH, A. W. NIENHUIS, C. E. MCLAREN, N. S. YOUNG, E. E. TUCKER, C. J. ALLEN, D. E. FARREL, & J. W. HARRIS. 1994. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. New. Engl. J. Med. 331: 567-573.
2. BERDOUKAS, V. & S. J. YAWALKAR. 1994. Desferal. Medical and Pharmaceutical information. Ciba-Geigy Ltd. Basle, Switzerland. Editorial completion, February.
3. KOREN, G., A. TESORO, J. S. LEEDER, Y. BENTUR & N. OLIVIERI. 1990. Stability of aqueous solutions of deferoxamine. Canad. J. Hosp. Pharmacy 43: 57-60.
4. TESORO, A., S. LEEDER & L. BENTURY. 1989. An HPLC method for the measurement of deferoxamine in body fluids. Drug. Monit. 11: 463-470.
5. PORTE, J. B., R. D. ABEYSINGHE, L. MARSHALL, R. C. HIDER & S. SINGH. 1996. Kinetics of removal and reappearance of non transferin bound plasma iron with deferoxamine therapy. Blood 88: 705-713.
6. ARAUJO, A., M. KOSARYAN, A. MC DOWELL, D. WICKENS, S. PURI, B. WONKE & A. V. HOFFBRAND. 1996. A novel delivery system for continuous desferrioxamine infusion in transfusional iron overload. Brit. J. Haematol. 93: 835-837.